BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis (Q41996948)
Jump to navigation
Jump to search
scientific article published on 16 February 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis |
scientific article published on 16 February 2017 |
Statements
1 reference
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis (English)
1 reference
Sabrina Cipriani
Maria Chiara Monti
Chiara Santorelli
Annibale Donini
16 February 2017
1 reference
16 February 2017
1 reference